bioRxiv ScienceSearch

Biology subjects

Lynn, D. M.

Publications and source records attributed to Lynn, D. M..

2 recordsLinked to original sources

Preventing S. aureus biofilm formation on titanium surfaces by the release of antimicrobial β-peptides from polyelectrolyte multilayers

Staphylococcus aureus infections represent the major cause of titanium based-orthopaedic implant failure. Current treatments for S. aureus infections involve the systemic delivery of antibiotics and additional surgeries, increasing health-care costs and affecting patients quality of life. As a step toward the development of new strategies that can prevent these infections, we build upon previous work demonstrating that the colonization of catheters by the fungal pathogen Candida albicans can be prevented by coating them with thin polymer multilayers composed of chitosan (CH) and hyaluronic acid (HA) designed to release a {beta}-amino acid-based peptidomimetic of antimicrobial peptides (AMPs). We demonstrate here that this {beta}-peptide is also potent against S. aureus (MIC = 4 {micro}g/mL) and characterize its selectivity toward S. aureus biofilms. We demonstrate further that {beta}-peptide-containing CH/HA thin-films can be fabricated on the surfaces of rough planar titanium substrates in ways that allow mammalian cell attachment and permit the long-term release of {beta}-peptide. {beta}-Peptide loading on CH/HA thin-films was then adjusted to achieve release of {beta}-peptide quantities that selectively prevent S. aureus biofilms on titanium substrates in vitro for up to 24 days and remained antimicrobial after being challenged sequentially five times with S. aureus inocula, while causing no significant MC3T3-E1 preosteoblast cytotoxicity compared to uncoated and film-coated controls lacking {beta}-peptide. We conclude that these {beta}-peptide-containing films offer a novel and promising localized delivery approach for preventing orthopaedic implant infections. The facile fabrication and loading of {beta}-peptide-containing films reported here provides opportunities for coating other medical devices prone to biofilm-associated infections.\n\nSTATEMENT OF SIGNIFICANCETitanium (Ti) and its alloys are used widely in internal fixation devices due to their mechanical strength and long-term biocompatibility. However, these devices are susceptible to bacterial colonization and the subsequent formation of biofilms. Here we report a chitosan and hyaluronic acid polyelectrolyte multilayer-based approach for the localized delivery of helical, cationic, globally amphiphilic {beta}-peptide mimetics of antimicrobial peptides to inhibit S. aureus colonization and biofilm formation. Our results reveal that controlled release of this {beta}-peptide can selectively kill S. aureus cells without exhibiting toxicity toward MC3T3-E1 preosteoblast cells. Further development of this polymer-based coating could result in new strategies for preventing orthopaedic implant-related infections, improving outcomes of these titanium implants.

bioengineering

14-helical β-peptides Elicit Toxicity against C. albicans by Forming Pores in the Cell Membrane and Subsequently Disrupting Intracellular Organelles

Synthetic peptidomimetics of antimicrobial peptides are promising as antimicrobial drug candidates because they promote membrane disruption and exhibit greater structural and proteolytic stability. We previously reported selective antifungal 14-helical {beta}-peptides, but the mechanism of antifungal toxicity of {beta}-peptides remains unknown. To provide insight into the mechanism, we studied antifungal {beta}-peptide binding to artificial membranes and living Candida albicans cells. We investigated the ability of {beta}-peptides to interact with and permeate small unilamellar vesicle models of fungal and bacterial membranes. The partition coefficient supported a pore-mediated mechanism characterized by the existence of a critical {beta}-peptide concentration separating low and high partition coefficient regimes. Live cell intracellular tracking of {beta}-peptides showed that {beta}-peptides translocated into the cytoplasm, and then disrupted the nucleus and vacuole sequentially, leading to cell death. This understanding of the mechanisms of antifungal activity will facilitate design and development of peptidomimetic AMPs, including 14-helical {beta}-peptides, for antifungal applications.\n\nGraphical Abstract\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=46 SRC=\"FIGDIR/small/430850_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (14K):\norg.highwire.dtl.DTLVardef@10ee335org.highwire.dtl.DTLVardef@66da40org.highwire.dtl.DTLVardef@82d132org.highwire.dtl.DTLVardef@7429e1_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering